Qube Research & Technologies (QRT)
PRQR icon

Qube Research & Technologies (QRT)’s ProQR Therapeutics PRQR Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio PRQR Stock Details PRQR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$535K Buy
+322,176
New +$610K ﹤0.01% 2885
2024
Q3 		– Sell
-33
Closed -$55 – 3938
2024
Q2 		$55 Hold
33
– – ﹤0.01% 3497
2024
Q1 		$75 Hold
33
– – ﹤0.01% 4196
2023
Q4 		$65 Hold
33
– – ﹤0.01% 4053
2023
Q3 		$43 Buy
+33
New +$52 ﹤0.01% 3827

Other funds holding PRQR

Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $72.4B AUM 31.32% 1-Year Est. Return
Privium Fund Management
Privium Fund Management Amsterdam, Netherlands $516M AUM 18.66% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $294B AUM 47.59% 1-Year Est. Return
Monaco Asset Management
Monaco Asset Management Monaco $818M AUM 32.61% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $375B AUM 21.05% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Jane Street
Jane Street New York $1.19T AUM 51.51% 1-Year Est. Return
Persistent Asset Partners
Persistent Asset Partners Hong Kong $362M AUM 191.92% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return
Franklin Street Advisors
Franklin Street Advisors Chapel Hill, North Carolina $1.82B AUM 22.19% 1-Year Est. Return

Qube Research & Technologies (QRT)'s PRQR Position: Q3 2026 in Review

Qube Research & Technologies (QRT) opened a new position in ProQR Therapeutics (PRQR) in Q3 2026: 322,176 shares worth $535K. The stake represents ﹤0.01% of the portfolio and ranks #2885 among its holdings. This is a return to the name: Qube Research & Technologies (QRT) previously reported a position in PRQR as recently as Q2 2024.

Qube Research & Technologies (QRT) first reported a position in PRQR in Q3 2023 and has held it in 5 quarters since. 34 funds tracked by Wall St. Rank hold PRQR as of Q3 2026.

  • Qube Research & Technologies (QRT) held 322,176 shares of ProQR Therapeutics worth $535K as of Q3 2026.
  • ProQR Therapeutics was a new Qube Research & Technologies (QRT) position in Q3 2026.
  • ProQR Therapeutics made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q3 2026, its #2885 holding.
  • Qube Research & Technologies (QRT) first reported a position in ProQR Therapeutics in Q3 2023 and has held it in 5 quarters since.
  • 34 funds tracked by Wall St. Rank held ProQR Therapeutics as of Q3 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2026, filed 13 Nov 2026.